Skip to content
★ Sign in to follow
JT

James T. Miceli

Immunosyn Corp
Total declarations
61
Company
1
▲ Purchases (23 ops.)
€6.9B
▼ Sales (29 ops.)
€15.6B

Latest filing published 15 Apr 2010 for IMMUNOSYN CORP.

Insider track record

Disclosed buys
23
Disclosed sells
29
Signal history

No signal scores available.

Closed purchases

Market purchases
23

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

James T. Miceli: trading record in brief

James T. Miceli appears in our data through filings on Immunosyn Corp shares, published by SEC (Form 4). The record holds 61 filings, for trades running from 26 April 2007 to 31 August 2009.

On the open market, the record shows 23 purchases worth €6.9B and 29 sales worth €15.6B. The amount is not disclosed for 5 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2010 alone, the filings show 19 purchases and no sales.

Half of the purchases are above €1,570 and half below.

The newest entry dates from 15 April 2010: a transaction, in Immunosyn Corp. The last insider purchase was made public on 15 April 2010, 6,051 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James T. Miceli

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations59 total
  • ●
    10% OwnerExecutivesImmunosyn Corp
    0SEC
    500,000 shares0Common StockSEC:0001437749-10-001101:0
  • ●
    10% OwnerExecutivesImmunosyn Corp
    0SEC
    12,710,000 shares0Common StockSEC:0001437749-10-001101:1
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    700 USD0SEC
    10,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:2
    Canonical exit: 5 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    1,720 USD0SEC
    21,500 shares@ US$0.08Common StockSEC:0001437749-10-001101:3
    Canonical exit: 6 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    1,350 USD0SEC
    15,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:4
    Canonical exit: 6 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    800 USD0SEC
    10,000 shares@ US$0.08Common StockSEC:0001437749-10-001101:5
    Canonical exit: 11 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    950 USD0SEC
    10,000 shares@ US$0.095Common StockSEC:0001437749-10-001101:6
    Canonical exit: 12 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    900 USD0SEC
    10,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:7
    Canonical exit: 12 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    4,635 USD0SEC
    51,500 shares@ US$0.09Common StockSEC:0001437749-10-001101:8
    Canonical exit: 13 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    950 USD0SEC
    10,000 shares@ US$0.095Common StockSEC:0001437749-10-001101:9
    Canonical exit: 13 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    3,500 USD0SEC
    50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:10
    Canonical exit: 28 Sept 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    171 USD0SEC
    2,857 shares@ US$0.06Common StockSEC:0001437749-10-001101:11
    Canonical exit: 4 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    900 USD0SEC
    10,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:12
    Canonical exit: 8 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    2,700 USD0SEC
    30,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:13
    Canonical exit: 12 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    1,022 USD0SEC
    12,780 shares@ US$0.08Common StockSEC:0001437749-10-001101:14
    Canonical exit: 18 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    4,000 USD0SEC
    50,000 shares@ US$0.08Common StockSEC:0001437749-10-001101:15
    Canonical exit: 20 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    175 USD0SEC
    2,500 shares@ US$0.07Common StockSEC:0001437749-10-001101:16
    Canonical exit: 20 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    3,500 USD0SEC
    50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:17
    Canonical exit: 25 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    3,500 USD0SEC
    50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:18
    Canonical exit: 26 Oct 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    4,620 USD0SEC
    77,000 shares@ US$0.06Common StockSEC:0001437749-10-001101:19
    Canonical exit: 24 Nov 2009 (T+90)
  • ▲
    10% OwnerExecutivesImmunosyn Corp
    5,000 USD0SEC
    100,000 shares@ US$0.05Common StockSEC:0001437749-10-001101:20
    Canonical exit: 29 Nov 2009 (T+90)
  • ●
    10% OwnerExecutivesImmunosyn Corp
    0SEC
    5,000 shares0Common StockSEC:0000950120-07-000699:0
  • ▼
    10% OwnerExecutivesImmunosyn Corp
    193,163 USD0SEC
    38,632.5 shares@ US$5.00Common StockSEC:0000950120-07-000679:0
  • ●
    10% OwnerExecutivesImmunosyn Corp
    0SEC
    161,550 shares0Common StockSEC:0000950120-07-000679:1
  • ▼
    10% OwnerExecutivesImmunosyn Corp
    67,568 USD0SEC
    14,850 shares@ US$4.55Common StockSEC:0000950120-07-000679:2

25 of 59 declarations